Philips and Subsidiaries Including Philips Respironics Resolves US Economic Loss Litigation, Earmarked €575M in Q1
Portfolio Pulse from Benzinga Newsdesk
Royal Philips and its US subsidiaries, including Philips Respironics, have reached an agreement to resolve all economic loss claims in the US Multidistrict Litigation related to Philips Respironics' voluntary recall of certain sleep and respiratory care devices. Philips Respironics has recorded a provision of EUR 575 million in Q1 2023 to cover the estimated costs of the final settlement. Payments to class members under the settlement are not expected to begin until Q1 2024.

September 07, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Philips has reached a settlement in a US litigation case, setting aside €575M for the estimated costs. This could impact the company's financials in the short term.
The settlement of the litigation case and the significant amount set aside for it could potentially impact Philips' financial performance in the short term. This could lead to a negative sentiment among investors, potentially affecting the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100